Merge wins clinical trials software deal in China

Merge Healthcare ($MRGE) has nailed down a new customer for its clinical trial management system (CTMS) software in China. Tigermed Consulting, a CRO based in Shanghai, has opted to use Merge's CTMS for sponsors and CROs to efficiently advance studies. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.